IL161099A0 - New anhydrous crystalline forms of gabapentin - Google Patents
New anhydrous crystalline forms of gabapentinInfo
- Publication number
- IL161099A0 IL161099A0 IL16109902A IL16109902A IL161099A0 IL 161099 A0 IL161099 A0 IL 161099A0 IL 16109902 A IL16109902 A IL 16109902A IL 16109902 A IL16109902 A IL 16109902A IL 161099 A0 IL161099 A0 IL 161099A0
- Authority
- IL
- Israel
- Prior art keywords
- gabapentin
- crystalline forms
- anhydrous crystalline
- new anhydrous
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/38—Separation; Purification; Stabilisation; Use of additives
- C07C227/40—Separation; Purification
- C07C227/42—Crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32837501P | 2001-10-09 | 2001-10-09 | |
| US10/256,155 US6800782B2 (en) | 2001-10-09 | 2002-09-25 | Anhydrous crystalline forms of gabapentin |
| PCT/US2002/031706 WO2003031391A1 (en) | 2001-10-09 | 2002-10-03 | New anhydrous crystalline forms of gabapentin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL161099A0 true IL161099A0 (en) | 2004-08-31 |
Family
ID=26945177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16109902A IL161099A0 (en) | 2001-10-09 | 2002-10-03 | New anhydrous crystalline forms of gabapentin |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6800782B2 (es) |
| EP (1) | EP1463712A1 (es) |
| JP (1) | JP2005505594A (es) |
| KR (1) | KR20050033525A (es) |
| CN (1) | CN1568305A (es) |
| AP (1) | AP2004003025A0 (es) |
| BG (1) | BG108702A (es) |
| BR (1) | BR0213156A (es) |
| CA (1) | CA2462331A1 (es) |
| CO (1) | CO5570697A2 (es) |
| CZ (1) | CZ2004416A3 (es) |
| EA (1) | EA006557B1 (es) |
| GE (1) | GEP20063936B (es) |
| HR (1) | HRP20040408A2 (es) |
| HU (1) | HUP0401782A3 (es) |
| IL (1) | IL161099A0 (es) |
| IS (1) | IS7195A (es) |
| MA (1) | MA27072A1 (es) |
| MX (1) | MXPA04003301A (es) |
| NO (1) | NO20041370L (es) |
| NZ (1) | NZ531993A (es) |
| OA (1) | OA12665A (es) |
| PL (1) | PL368117A1 (es) |
| RS (1) | RS28204A (es) |
| SK (1) | SK1572004A3 (es) |
| TN (1) | TNSN04055A1 (es) |
| WO (1) | WO2003031391A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070043236A1 (en) * | 2003-05-19 | 2007-02-22 | Chandiran Thakashina M | Process for preparation of gabapentin |
| WO2004106281A1 (en) * | 2003-05-30 | 2004-12-09 | Ranbaxy Laboratories Limited | Crystalline gabapentin |
| WO2004110342A2 (en) * | 2003-06-12 | 2004-12-23 | Matrix Laboratories Ltd | Novel polymorph of gabapentin and its conversion to gabapentin form-ii |
| US7169812B2 (en) * | 2003-07-01 | 2007-01-30 | Medtronic, Inc. | Process for producing injectable gabapentin compositions |
| ITMI20040579A1 (it) * | 2004-03-25 | 2004-06-25 | Zambon Spa | Processo di preparazione di gabapentina |
| WO2010023694A2 (en) * | 2008-09-01 | 2010-03-04 | Hikal Ltd | Crystalline forms of gabapentin and process thereof |
| CN104649921B (zh) * | 2015-01-14 | 2016-09-28 | 天津大学 | 一种加巴喷丁与己二酸共晶及其制备方法 |
| CN116693410B (zh) * | 2023-06-08 | 2024-06-07 | 浙江竹子制药有限公司 | 一种粒径可控的加巴喷丁制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4087544A (en) | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
| DE2460891C2 (de) | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| JPS62247160A (ja) * | 1986-03-31 | 1987-10-28 | Aisin Seiki Co Ltd | スタ−リングエンジンの始動装置 |
| US4894476A (en) | 1988-05-02 | 1990-01-16 | Warner-Lambert Company | Gabapentin monohydrate and a process for producing the same |
| US4960931A (en) | 1988-05-02 | 1990-10-02 | Warner-Lambert Company | Gabapentin mohohydrate and a process for producing the same |
| DE3928184A1 (de) | 1989-08-25 | 1991-02-28 | Goedecke Ag | Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte |
| IL119890A (en) | 1996-12-24 | 2002-03-10 | Teva Pharma | Gabapentin form iii and preparation of gabapentin form ii |
| ES2137137B1 (es) | 1998-05-25 | 2000-08-16 | Medichem Sa | Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica. |
-
2002
- 2002-09-25 US US10/256,155 patent/US6800782B2/en not_active Expired - Fee Related
- 2002-10-03 EA EA200400417A patent/EA006557B1/ru not_active IP Right Cessation
- 2002-10-03 MX MXPA04003301A patent/MXPA04003301A/es active IP Right Grant
- 2002-10-03 KR KR1020047005149A patent/KR20050033525A/ko not_active Application Discontinuation
- 2002-10-03 CN CNA02820056XA patent/CN1568305A/zh active Pending
- 2002-10-03 SK SK157-2004A patent/SK1572004A3/sk not_active Application Discontinuation
- 2002-10-03 WO PCT/US2002/031706 patent/WO2003031391A1/en active Application Filing
- 2002-10-03 EP EP02766485A patent/EP1463712A1/en not_active Withdrawn
- 2002-10-03 RS YU28204A patent/RS28204A/sr unknown
- 2002-10-03 IL IL16109902A patent/IL161099A0/xx unknown
- 2002-10-03 GE GE5594A patent/GEP20063936B/en unknown
- 2002-10-03 CA CA002462331A patent/CA2462331A1/en not_active Abandoned
- 2002-10-03 HU HU0401782A patent/HUP0401782A3/hu unknown
- 2002-10-03 OA OA1200400095A patent/OA12665A/en unknown
- 2002-10-03 NZ NZ531993A patent/NZ531993A/en unknown
- 2002-10-03 BR BR0213156-0A patent/BR0213156A/pt not_active IP Right Cessation
- 2002-10-03 JP JP2003534375A patent/JP2005505594A/ja active Pending
- 2002-10-03 PL PL02368117A patent/PL368117A1/xx not_active Application Discontinuation
- 2002-10-03 CZ CZ2004416A patent/CZ2004416A3/cs unknown
- 2002-10-03 AP APAP/P/2004/003025A patent/AP2004003025A0/en unknown
-
2004
- 2004-03-23 IS IS7195A patent/IS7195A/is unknown
- 2004-04-01 NO NO20041370A patent/NO20041370L/no not_active Application Discontinuation
- 2004-04-05 MA MA27606A patent/MA27072A1/fr unknown
- 2004-04-06 CO CO04032599A patent/CO5570697A2/es not_active Application Discontinuation
- 2004-04-07 TN TNP2004000055A patent/TNSN04055A1/fr unknown
- 2004-04-28 BG BG108702A patent/BG108702A/xx unknown
- 2004-05-07 HR HR20040408A patent/HRP20040408A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0401782A3 (en) | 2006-01-30 |
| BG108702A (en) | 2005-05-31 |
| CO5570697A2 (es) | 2005-10-31 |
| IS7195A (is) | 2004-03-23 |
| JP2005505594A (ja) | 2005-02-24 |
| TNSN04055A1 (fr) | 2006-06-01 |
| SK1572004A3 (sk) | 2005-03-04 |
| NO20041370L (no) | 2004-04-01 |
| HRP20040408A2 (en) | 2004-10-31 |
| RS28204A (en) | 2006-12-15 |
| EA200400417A1 (ru) | 2004-10-28 |
| HUP0401782A2 (hu) | 2005-10-28 |
| MA27072A1 (fr) | 2004-12-20 |
| CN1568305A (zh) | 2005-01-19 |
| GEP20063936B (en) | 2006-10-10 |
| KR20050033525A (ko) | 2005-04-12 |
| US20030092933A1 (en) | 2003-05-15 |
| MXPA04003301A (es) | 2004-07-23 |
| EA006557B1 (ru) | 2006-02-24 |
| WO2003031391A1 (en) | 2003-04-17 |
| AP2004003025A0 (en) | 2004-06-30 |
| EP1463712A1 (en) | 2004-10-06 |
| NZ531993A (en) | 2006-09-29 |
| US6800782B2 (en) | 2004-10-05 |
| BR0213156A (pt) | 2004-09-14 |
| CA2462331A1 (en) | 2003-04-17 |
| CZ2004416A3 (cs) | 2005-03-16 |
| OA12665A (en) | 2006-06-19 |
| PL368117A1 (en) | 2005-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1070653A1 (en) | Novel crystalline compound | |
| ZA200410320B (en) | Crystallization of sugars | |
| HUP0500733A3 (en) | Crystallization of igf-1 | |
| IL159861A0 (en) | Crystalline forms of fluvastatin sodium | |
| PL369102A1 (en) | Set of teeth | |
| GB2383038B (en) | Anhydrous crystal form of valaciclovir hydrochloride | |
| IL157176A0 (en) | Purification of 2-nitro-4-methylsulphonylbenzoic acid | |
| IL161099A0 (en) | New anhydrous crystalline forms of gabapentin | |
| GB2407140B (en) | Mounting of tubes | |
| PL371427A1 (en) | New uses of substituted aminoalkanephosphonic acids | |
| PL366978A1 (en) | Hydroxyfattysulfonic acid analogs | |
| ZA200402519B (en) | New anhydrous crystalline forms of gabapentin. | |
| AU148464S (en) | Wristwatch | |
| HK1072424A1 (en) | Preparation of an anhydrous quinoline-based inhibitor by crystallization | |
| EP1486485A4 (en) | NEW 5-HYDROXYCARBAMIMIDOYL-2-HYDROXYBENZENESULFONAMIDE DERIVATIVE CRYSTALS | |
| TW543759U (en) | Improved structure for fin of evaporator | |
| GB0111083D0 (en) | Formation of small crystals | |
| GB0127380D0 (en) | Formation of small crystals | |
| GB0108226D0 (en) | Novel crystalline forms | |
| AP2002002566A0 (en) | Monohydrate of cis-lithium-cynao-4-Ä3-(cyclopentloxy)-4-methoxyphenylÜ cyclohexanecarboxylate | |
| HK1078562A1 (en) | Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2- methylhept-5-enoic acid | |
| SI1537210T1 (sl) | Lazna oligonukleotidna inhibicija ekspresije CD40 | |
| GB0106464D0 (en) | Crystalline therapeutic agent | |
| GB0200617D0 (en) | Characterisation of analytes | |
| GB0217750D0 (en) | New use of diaza-anthracene compounds |